Farallon Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,000
| Closed | -$230K | – | 163 |
|
|
2024
Q3 | $230K | Hold |
5,000
| – | – | ﹤0.01% | 129 |
|
|
2024
Q2 | $204K | Sell |
5,000
-601,061
| -99% | -$24.6M | ﹤0.01% | 131 |
|
|
2024
Q1 | $15.5M | Buy |
+606,061
| New | +$15.5M | 0.07% | 81 |
|
|
2020
Q3 | – | Sell |
-50,000
| Closed | -$1.41M | – | 131 |
|
|
2020
Q2 | $1.41M | Buy |
+50,000
| New | +$1.41M | 0.01% | 114 |
|